COLL Collegium Pharmaceutical Inc

Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conference in October:

• The 2019 Cantor Global Healthcare Conference on Thursday, October 3rd in New York City. Management will present at 4:10 p.m. ET and will also participate in investor meetings.  

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.

Contact: Alex Dasalla adasalla@collegiumpharma.com